Literature DB >> 24352245

Association between microvascular angina and erectile dsyfunction.

S Demirkol1, S Balta1, U Kucuk1, T Celik1, Z Arslan2, H Olgun Kucuk3, M Unlu4, U Cagdas Yuksel1, S Samedli1, M Yokusoglu1, A Iyisoy1, H Kursaklioglu1.   

Abstract

Although the origin of cardiac syndrome X (CSX) is still debated, endothelial dysfunction leading to reduced coronary microvascular dilatory response and increased coronary resistance is thought to have an important role in the pathogenesis. Erectile dysfunction (ED) is associated with risk factors resulting in endotelial dysfunction. Although the relationship between cardiovascular disease and ED has been well established; the relation between CSX and ED has not been extensively studied so far. We herein aimed to study ED in patients with CSX. The study was designed as a prospective case-control study. Blood samples were analyzed with respect to concentrations of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides. The subjects answered the native language five-item version of the International Index of Erectile Function Questionnaire (IIEF)-5. Each question was scored from 0 to 5 with a maximum score of 25 denoting healty subjects. We investigated the IIEF-5 score in 51 men with CSX (mean age=48.2±6.4 years), 53 men with demonstrated coronary artery disease (CAD) (mean age=48.3±4.8 years) and 52 male controls with normal coronary arteries (mean age=47.2±6.0 years). Mean IIEF-5 scores were 19.88±3.07 for CSX group, 18.83±3.31 for CAD group and 21.40±2.94 for control group. IIEF-5 scores in CSX group were found to be significantly lower than the those of control group (P<0.001). There were no significant differences in IIEF-5 scores between CSX and CAD groups (P=0.09). We have shown for the first time that patients with CSX have lower IIEF-5 scores compared with controls with normal coronary angiograms. This study suggests that ED and CSX may be different manifestations of a common underlying vascular pathology and vasculogenic ED is frequently seen in CSX at least as much as in CAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24352245     DOI: 10.1038/ijir.2013.49

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  23 in total

Review 1.  The worldwide prevalence and epidemiology of erectile dysfunction.

Authors:  J B McKinlay
Journal:  Int J Impot Res       Date:  2000-10       Impact factor: 2.896

2.  Erectile dysfunction and coronary slow flow: distinct presentations of endothelial disease.

Authors:  Z Nurkalem; C Kaya; A L Orhan; E Zencirci; A T Alper; E Kucuk; M Eren
Journal:  Int J Impot Res       Date:  2007-08-02       Impact factor: 2.896

Review 3.  Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction.

Authors:  Ashok Agarwal; Kalyana C Nandipati; Rakesh K Sharma; Craig D Zippe; Rupesh Raina
Journal:  J Androl       Date:  2005-12-08

4.  Vascular risk factors for erectile dysfunction.

Authors:  Culley C Carson
Journal:  J Urol       Date:  2007-10-22       Impact factor: 7.450

5.  Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation.

Authors:  P Tondi; A Santoliquido; A Di Giorgio; A Sestito; G A Sgueglia; R Flore; G Careri; G Pinnacchio; G A Lanza; F Crea
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-09       Impact factor: 3.507

6.  Biochemical parameters of endothelial dysfunction in cardiological syndrome X.

Authors:  W Kolasińska-Kloch; W Leśniak; B Kieć-Wilk; M Malczewska-Malec
Journal:  Scand J Clin Lab Invest       Date:  2002       Impact factor: 1.713

7.  Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.

Authors:  Mustafa Gur; Ali Yildiz; Recep Demirbag; Remzi Yilmaz; Mehmet Aslan; Ibrahim Ozdogru; Ozcan Erel
Journal:  Coron Artery Dis       Date:  2007-03       Impact factor: 1.439

8.  Assessment of the relationship between coronary artery ectasia and erectile function score.

Authors:  A B Akcay; M Inci; P Bilen; A Acele; N Sen; F Yalcin
Journal:  Int J Impot Res       Date:  2011-04-28       Impact factor: 2.896

9.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

Authors:  Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

10.  Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men.

Authors:  R Virag; P Bouilly; D Frydman
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

View more
  4 in total

1.  Waist-Hip Ratio in Patients with Acute Myocardial Infarction.

Authors:  Sevket Balta; Ugur Kucuk; Sait Demirkol; Cengiz Oztur; Mustafa Demir
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 2.  Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy.

Authors:  Jenna Dean; Sherwin Dela Cruz; Puja K Mehta; C Noel Bairey Merz
Journal:  Nat Rev Cardiol       Date:  2015-05-26       Impact factor: 32.419

3.  Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus.

Authors:  Kae-Woei Liang; Wayne H-H Sheu; Wen-Jane Lee; Wen-Lieng Lee; Hung-Chih Pan; I-Te Lee; Jun-Sing Wang
Journal:  Diabetol Metab Syndr       Date:  2017-02-08       Impact factor: 3.320

4.  Endocan and Erectile Dysfunction.

Authors:  Sevket Balta; Dimitri P Mikhailidis
Journal:  Am J Mens Health       Date:  2019 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.